Evidence map›Paper›PMID 34595949›Full record

ArticleJournal of managed care & specialty pharmacy2021

Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C.

Xinyi Jiang, Scott Martin Vouri, Vakaramoko Diaby, Weihsuan Lo-Ciganic, Robert Parker, Haesuk Park

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xinyi JiangDepartment of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville.
Scott Martin VouriDepartment of Pharmaceutical Outcomes & Policy, Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville.
Vakaramoko DiabyDepartment of Pharmaceutical Outcomes & Policy, Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville.
Weihsuan Lo-CiganicDepartment of Pharmaceutical Outcomes & Policy, Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville.
Robert ParkerDepartment of Biostatistics, College of Public Health & Health Professions, College of Medicine, University of Florida, Gainesville.
Haesuk ParkDepartment of Pharmaceutical Outcomes & Policy, Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville.
University of Florida · US

Funding

Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable PopulationsK01DA045618 · NIDA · UNIVERSITY OF FLORIDA · PI PARK, HAESUK · 2018 to 2022
$648k
NIDA NIH HHS K01 DA045618
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health Care CostsPatient Acceptance of Health CareSubstance-Related DisordersAdolescentAdultAgedAntiviral AgentsFemaleHepatitis C, ChronicHumansInsurance Claim ReviewMaleMedicareMiddle AgedRetrospective StudiesUnited StatesAntiviral Agents

Identifiers

PMID34595949
PMCPMC8968723
OpenAlexW3202553606

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.